ConductScience.org, home

Paper36937361

Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy.

Zhang Y and 5 others. Front Nutr, 2023. Cited by 90 papers, by iCite.

Cite this record

ConductScience Library. Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy. Papers, record 36937361. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36937361

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy.
PubMed
Journal
Front Nutr
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
90
iCite
Relative citation ratio, by iCite
12.6
iCite
Revised in PubMed
2023-03-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang YYaoyuan
2Zhu XXiao
3Yu XXinyuan
4Novák PPetr
5Gui QQingjun
6Yin KKai

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References261

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132016468Impact of a high‑fat diet on intestinal stem cells and epithelial barrier function in middle‑aged female mice.Mol Med Rep2020https://conductscience.org/library/papers/32016468PubMed
231266545Dietary fibre and cardiovascular health: a review of current evidence and policy.Proc Nutr Soc2020https://conductscience.org/library/papers/31266545PubMed
328504618Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice.Exp Biol Med (Maywood)2017https://conductscience.org/library/papers/28504618PubMed
434703027Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities.Nat Rev Endocrinol2022https://conductscience.org/library/papers/34703027PubMed
530366260Gut microbiome and type 2 diabetes: where we are and where to go?J Nutr Biochem2019https://conductscience.org/library/papers/30366260PubMed
627713957Antidiabetic (type 2) effects of Lactobacillus G15 and Q14 in rats through regulation of intestinal permeability and microbiota.Food Funct2016https://conductscience.org/library/papers/27713957PubMed
734507723Vitamin A supplementation ameliorates ulcerative colitis in gut microbiota-dependent manner.Food Res Int2021https://conductscience.org/library/papers/34507723PubMed
822344613Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study).Diabetes Care2012https://conductscience.org/library/papers/22344613PubMed
929984492Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes.J Pathol2018https://conductscience.org/library/papers/29984492PubMed
1033221482Abnormal food timing and predisposition to weight gain: Role of barrier dysfunction and microbiota.Transl Res2021https://conductscience.org/library/papers/33221482PubMed
1125561785Role of interleukin-22 in inflammatory bowel disease.World J Gastroenterol2014https://conductscience.org/library/papers/25561785PubMed
1232986965Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease.Am J Physiol Heart Circ Physiol2020https://conductscience.org/library/papers/32986965PubMed
1326102296Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota.Nat Commun2015https://conductscience.org/library/papers/26102296PubMed
1431206525Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice.PLoS One2019https://conductscience.org/library/papers/31206525PubMed
1528654658Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway.PLoS One2017https://conductscience.org/library/papers/28654658PubMed
1618437274Influence of high and low protein intakes on age-related bone loss in rats submitted to adequate or restricted energy conditions.Calcif Tissue Int2008https://conductscience.org/library/papers/18437274PubMed
1725865369Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function.Cell Host Microbe2015https://conductscience.org/library/papers/25865369PubMed
1833162192Effects of soluble fiber supplementation on glycemic control in adults with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.Clin Nutr2021https://conductscience.org/library/papers/33162192PubMed
1934058177Metformin impairs bile acid homeostasis in ethinylestradiol-induced cholestasis in mice.Chem Biol Interact2021https://conductscience.org/library/papers/34058177PubMed
2032747812Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects.Nat Chem Biol2021https://conductscience.org/library/papers/32747812PubMed

See all 261 referencesDownload CSV of references

Cited by70

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.

PMIDTitleJournalYearIn PapersSource
42940217Probiotic-Postbiotic Synergy and Microbial Co-Culture Strategies for Hyperuricemia: Gut Microbiota and Functional Food Perspectives.Foods2026https://conductscience.org/library/papers/42940217PubMed
42935632Gut Microbiota as a Mechanistic Nexus between Type 2 Diabetes and Alzheimer's Disease: Insulin Resistance, Neuroinflammation, and Functional Food Strategies.Prev Nutr Food Sci2026https://conductscience.org/library/papers/42935632PubMed
42862482Toxic Metals and Metalloids Exposure and the Gut-Cardiometabolic Axis: A Narrative Review of Microbiome Dysbiosis, Gut Barrier Dysfunction, and Metabolic Inflammation.Cardiovasc Toxicol2026https://conductscience.org/library/papers/42862482PubMed
42859560Gut microbiota dysbiosis: Pathogenic drivers and emerging phage-based therapeutics.AIMS Microbiol2026https://conductscience.org/library/papers/42859560PubMed
42764900Advances of oral micro- and nanomedicines for modulating intestinal barriers in the treatment of intestinal diseases.Acta Pharm Sin B2026https://conductscience.org/library/papers/42764900PubMed
42737658Effects of a Chemically Characterised Multi-Component Nutraceutical Formulation on Intestinal, Hepatic and Skeletal Muscle Responses in an In Vitro Gut-Liver-Muscle Model.Int J Mol Sci2026https://conductscience.org/library/papers/42737658PubMed
42723815Association of glucagon-like peptide-1 receptor agonists with atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis.Front Cardiovasc Med2026https://conductscience.org/library/papers/42723815PubMed
42640624Gut microbial diversity at baseline conditions the clinical, microbiome, and metabolic response to paraprobiotic Lactiplantibacillus plantarum LRCC5282 in overweight adults.Gut Microbes2026https://conductscience.org/library/papers/42640624PubMed
42482485Intestinal Organoids as Models to Study Viruses: Current Application and Future Perspective.J Microbiol Biotechnol2026https://conductscience.org/library/papers/42482485PubMed
42444516Intestinal gases as markers to study the diet-gut microbiota-host metabolism axis in humans and their relationship to metabolic health.Gut Microbes2026https://conductscience.org/library/papers/42444516PubMed
42295694Hypocholesterolemic agents and the gut microbiota: a review of interactions and modulatory activity.Pharmacol Rep2026https://conductscience.org/library/papers/42295694PubMed
42280144Natural Bioactive Compounds Targeting Gut Barrier Integrity and Metabolic Endotoxemia in Cardiometabolic Disease: Mechanistic Insights and Translational Perspectives.Molecules2026https://conductscience.org/library/papers/42280144PubMed
42131237Gut microbiota-liver-kidney axis in diabetic kidney disease: mechanistic insights into amino acid metabolism and nutritional intervention strategies targeting natural bioactive compounds.Front Nutr2026https://conductscience.org/library/papers/42131237PubMed
42075146Effects of the Synbiotic Formulation EDC-HHA01 on Glucose Regulation in Adults with Type 2 Diabetes and Prediabetes: A Randomized, Placebo-Controlled Study.Microorganisms2026https://conductscience.org/library/papers/42075146PubMed
42051455Gut microbiome dysbiosis in PCOS: from pathogenesis to microbiome-targeted therapies.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42051455PubMed
41939722Food-derived molecules as regulators of intestinal tight junctions and barrier function: mechanisms and implications.Front Drug Deliv2026https://conductscience.org/library/papers/41939722PubMed
41915357Odevixibat ameliorates high-fat diet-induced MASLD in mice by targeting the gut microbiota-metabolite axis and enhancing gut-liver crosstalk.J Physiol Biochem2026https://conductscience.org/library/papers/41915357PubMed
41900814Natural Extract Combination Modulates Intestinal Barrier and Hepatic Cholesterol via the Gut-Liver Axis In Vitro.Pharmaceutics2026https://conductscience.org/library/papers/41900814PubMed
41872245Semaglutide restores metabolic and structural homeostasis along the gut-heart-metabolic axis in a cafeteria diet-induced obesity model.Sci Rep2026https://conductscience.org/library/papers/41872245PubMed
41834567Limosilactobacillus reuteri ATG-F4 Ameliorates Dexamethasone-Induced Muscle Atrophy through Modulation of Gut Microbiota.J Microbiol Biotechnol2026https://conductscience.org/library/papers/41834567PubMed

See all 70 cited byDownload CSV of cited by

Genes19

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
CDX21045PubTator's text mininghttps://conductscience.org/library/genes/1045NCBI Gene
CGN57530PubTator's text mininghttps://conductscience.org/library/genes/57530NCBI Gene
CLDN19076PubTator's text mininghttps://conductscience.org/library/genes/9076NCBI Gene
CLDN29075PubTator's text mininghttps://conductscience.org/library/genes/9075NCBI Gene
FCGBP8857PubTator's text mininghttps://conductscience.org/library/genes/8857NCBI Gene
GCG2641PubTator's text mininghttps://conductscience.org/library/genes/2641NCBI Gene
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740NCBI Gene
HP3240PubTator's text mininghttps://conductscience.org/library/genes/3240NCBI Gene
IL2250616PubTator's text mininghttps://conductscience.org/library/genes/50616NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
MLC123209PubTator's text mininghttps://conductscience.org/library/genes/23209NCBI Gene
MYLK391807PubTator's text mininghttps://conductscience.org/library/genes/91807NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
OCLN100506658PubTator's text mininghttps://conductscience.org/library/genes/100506658NCBI Gene
PRKAA25563PubTator's text mininghttps://conductscience.org/library/genes/5563NCBI Gene
TJP17082PubTator's text mininghttps://conductscience.org/library/genes/7082NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene
ZG16653808PubTator's text mininghttps://conductscience.org/library/genes/653808NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36937361

GET https://conductscience.org/api/papers/v1/36937361/references?page=2